Noah Lechtzin
Director, Adult Cystic Fibrosis Program · Johns Hopkins University School of Medicine
Credentials: · · · ·
History
1997–2000- 1994–1997
Internal Medicine
- 1990–1994
Research
JAMA · 2010 · 290 citations
Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis
American Journal of Respiratory and Critical Care Medicine · 2008 · 276 citations
Science Translational Medicine · 2018 · 258 citations
14 papers
14 papers
12 papers
11 papers
11 papers
11 papers
11 papers
9 papers
Grants
- 2016–2020
Ph 1-2 Study of Glycerolphenylbutyrate for Cystic Fibrosis IND 125,124 (12/5/15)
Food and Drug Administration · R01
Contact PI · $19.5K · National Jewish Health
- 2010–2016
Early Intervention in Pulmonary Exacerbation in CF
National Heart, Lung, and Blood Institute · R01
PI · $3.8M · University of Washington
- 2002–2007
Improving Respiratory Outcomes in ALS
National Heart, Lung, and Blood Institute · K23
Contact PI · $657.5K · Johns Hopkins University
Clinical trials
- 2020–2021
Cystic Fibrosis Remote Monitoring System
Principal investigator · Unknown
Koronis Biomedical Technologies
- 2011–2015
Early Intervention in Cystic Fibrosis Exacerbation
Principal investigator · Completed
Johns Hopkins University
- 2004–2005
Principal investigator · Completed · Phase 3
Johns Hopkins University
- 2002–2007
Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement
Principal investigator · Completed · Phase 2, Phase 3
Johns Hopkins University